UNSPSC 85751101: Revision of nonautologous tissue substitute in prostate and seminal vesicles, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of nonautologous tissue substitute in prostate and seminal vesicles, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0VW40KZ

UNSPSC 85751101 Revision of nonautologous tissue substitute in prostate and seminal vesicles, open approach is a Commodity code that shows little relevant recent activity. The code's nominal scope describes a specific surgical procedure, but the six state and local opportunities posted between July and September 2026 and tagged under this code cover unrelated work: independent medical evaluation services for pension disability determinations, surgical benefit carve-outs for employee health plans, occupational medical surveillance, specialty medical services for detained youth, pharmacy benefit management, and temporary health professional staffing. None of these solicitations involve tissue substitutes, urologic surgery, or the procedure named in the code. The mismatch between the code's definition and the actual work being solicited suggests either a classification error by the issuing bodies or a gap in UNSPSC alignment within state and local procurement systems.

The issuing bodies span multiple jurisdictions and service lines: the City of Phoenix Retirement Office (disability medical evaluations), City of Long Beach (employee surgical benefits), Washington State Department of Transportation (occupational health surveillance), Harris County Juvenile Probation Department (youth detention medical services), Collier County (pharmacy management), and County of Santa Clara Health System (temporary clinical staffing). Geographic activity is scattered across Arizona, California, Florida, and Washington, with no concentration. Given the absence of opportunities genuinely aligned with urologic tissue substitute procedures, firms pursuing work under this code should verify UNSPSC classification directly with issuing bodies before bid preparation.